1 false false false false false false false false false false true false false false false false false No description of principal activity 2024-04-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 14702343 2024-04-01 2025-03-31 14702343 2025-03-31 14702343 2024-03-31 14702343 2023-03-03 2024-03-31 14702343 2024-03-31 14702343 2023-03-02 14702343 bus:Director1 2024-04-01 2025-03-31 14702343 core:WithinOneYear 2025-03-31 14702343 bus:Micro-entities 2024-04-01 2025-03-31 14702343 bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 14702343 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 14702343 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 14702343 bus:FullAccounts 2024-04-01 2025-03-31
COMPANY REGISTRATION NUMBER: 14702343

HEPARIN THERAPEUTICS LIMITED

FILLETED UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED

31 March 2025

HEPARIN THERAPEUTICS LIMITED

BALANCE SHEET

31 March 2025

|  | Period from
| Year to | 3 Mar 23 to
| 31 Mar 25 | 31 Mar 24
| £ | £
Fixed assets | 1,913 | –
| ------ | ----

Current assets | 2,660 | 3

Creditors: amounts falling due within one year | ( 6,240) | –
| ------ | ----
Net current (liabilities)/assets | ( 3,580) | 3
| ------ | ----
Total assets less current liabilities | ( 1,667) | 3

Accruals and deferred income | ( 2,000) | –
| ------ | ----
| (3,667) | 3
| ------ | ----

Capital and reserves | ( 3,667) | 3
| ------ | ----

Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2024: Nil).
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 8 October 2025 , and are signed on behalf of the board by:

M B Brown |
Director |

Company registration number: 14702343
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 2 Crossways Business Centre,, Bicester Road, Kingswood, Aylesbury, HP18 0RA.